MedTrace Logo

Pan Facial Volume Restoration

NCT01545557 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2023-03-01

Study results available
· View outcomes & findings →

Summary

The aim of this study is to assess performance and tolerance as well as investigator and subject satisfaction further to pan-facial volume restoration with a new cross-linked hyaluronic acid dermal filler containing lidocaine 0.3%.

Conditions

  • Volume Loss (Soft Tissue Ptosis or Atrophy )

Interventions

DEVICE

Hyaluronic acid dermal filler gel

1 Emervel Volume injection per indication and 1 touch-up injection if necessary

Sponsors & Collaborators

  • Galderma R&D

    lead INDUSTRY

Principal Investigators

  • Clinical Scientist · Galderma R&D

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-02-21
Primary Completion
2014-03-03
Completion
2014-03-03

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01545557 on ClinicalTrials.gov